4basebio AG announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was EUR 212,000 compared to EUR 297,000 a year ago. Operating loss was EUR 1.591 million compared to EUR 511,000 a year ago. Net loss was EUR 1.870 million compared to EUR 1.322 million a year ago. For the half year, sales was EUR 507,000 compared to EUR 592,000 a year ago. Operating loss was EUR 2.220 million compared to EUR 1.388 million a year ago. Net income was EUR 63.858 million compared to net loss of EUR 1.785 million a year ago.